Literature DB >> 4036925

Effectiveness of mumps vaccine in a school outbreak.

K M Sullivan, T J Halpin, J S Marks, R Kim-Farley.   

Abstract

An outbreak of mumps in a middle school (grades 6 through 8) in Ohio during 1981 was investigated to determine the effectiveness of mumps vaccine. Of the 481 middle school students on whom questionnaires were completed, 62 (12.4%) exhibited clinical mumps. The overall vaccine efficacy was 81.2% when children with a history of mumps disease are excluded from the analysis. Using a logistic regression model with the presence or absence of clinical mumps as the dependent variable, three factors were found to be significant: mumps vaccine, a history of mumps disease, and sex. Factors that did not significantly affect the rate of disease among vaccinated pupils included whether the mumps vaccine was administered singly or in combination with rubella and/or measles vaccine, age at vaccination, year of vaccination, and month of vaccination.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4036925     DOI: 10.1001/archpedi.1985.02140110063030

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  11 in total

1.  Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009-2010.

Authors:  Preeta Krishnan Kutty; Jacqueline Lawler; Elizabeth Rausch-Phung; Ismael R Ortega-Sanchez; Stephen Goodell; Cynthia Schulte; Lynn Pollock; Barbara Valure; Jean Hudson; Kathleen Gallagher; Debra Blog
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

Review 2.  Mumps: an Update on Outbreaks, Vaccine Efficacy, and Genomic Diversity.

Authors:  Eugene Lam; Jennifer B Rosen; Jane R Zucker
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

3.  Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays.

Authors:  Jeremy Mauldin; Kathryn Carbone; Henry Hsu; Robert Yolken; Steven Rubin
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey.

Authors:  C Amela; I Pachón; F de Ory
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

5.  Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.

Authors:  Cheryl Cohen; Joanne M White; Emma J Savage; Judith R Glynn; Yoon Choi; Nick Andrews; David Brown; Mary E Ramsay
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

6.  [A look back at 2 mumps outbreaks].

Authors:  M F Paccaud; P Hazeghi; M Bourquin; A M Maurer; C A Steiner; A J Seiler; P Helbling; H Zimmermann
Journal:  Soz Praventivmed       Date:  1995

7.  [Mumps epidemiology in Switzerland: results from the Sentinella surveillance system 1986-1993. Sentinella Work Group].

Authors:  H Zimmermann; H C Matter; T Kiener
Journal:  Soz Praventivmed       Date:  1995

8.  Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity.

Authors:  Christina Poethko-Müller; Annette Mankertz
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

9.  Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population.

Authors:  Anand A Date; Moe H Kyaw; Alison M Rue; Julie Klahn; Leann Obrecht; Terry Krohn; Josh Rowland; Steve Rubin; Thomas J Safranek; William J Bellini; Gustavo H Dayan
Journal:  J Infect Dis       Date:  2008-06-15       Impact factor: 7.759

10.  Can Machines Learn Respiratory Virus Epidemiology?: A Comparative Study of Likelihood-Free Methods for the Estimation of Epidemiological Dynamics.

Authors:  Heidi L Tessmer; Kimihito Ito; Ryosuke Omori
Journal:  Front Microbiol       Date:  2018-03-02       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.